Inventor · disambiguated record
Francesca Micoli
Also filed as: MICOLI FRANCESCA
10 granted patents·8 pending applications·7 citations·filing 2009–2024
81Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA12NOVARTIS AG2BERTI FRANCESCO1COSTANTINO PAOLO1MICOLI FRANCESCA1
Top patents by PatentIndex Score
18 records- 0179US9173954B2Polysaccharide immunogens conjugated to E. coli carrier proteinsCOSTANTINO PAOLO·Filed 2010·Granted Nov 3, 2015·3 cites·13 claims
- 0275US9358284B2Methods for making saccharide-protein glycoconjugatesSAUL ALLAN JAMES·Filed 2012·Granted Jun 7, 2016·2 cites·19 claims
- 0373US10124051B2Meningococcus serogroup X conjugateNOVARTIS AG·Filed 2013·Granted Nov 13, 2018·2 cites·11 claims
- 0471US10683370B2Methods for making saccharide-protein glycoconjugatesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Jun 16, 2020·0 cites·23 claims
- 0566US2024293524A1MULTIPLE FUNCTIONALIZED noMV CONJUGATESGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 0665US10668143B2Meningococcus serogroup X conjugateGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Jun 2, 2020·0 cites·10 claims
- 0765US10113009B2Methods for making saccharide-protein glycoconjugatesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Oct 30, 2018·0 cites·13 claims
- 0862US2025215057A1Method for Preparing Outer Membrane VesiclesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 0959US2024358810A1Shigella VaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1059US2011142876A1Conjugated vi saccharidesMICOLI FRANCESCA·Filed 2009·Application pending·0 cites
- 1158US10098947B2Salmonella conjugate vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Oct 16, 2018·0 cites·20 claims
- 1254US12005109B2Multi-functionalized nOMV conjugatesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Jun 11, 2024·0 cites·14 claims
- 1354US9475846B2Conjugated Vi saccharidesNOVARTIS AG·Filed 2012·Granted Oct 25, 2016·0 cites·5 claims
- 1452US2024102978A1Improved method for polysaccharide quantificationGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 1551US2024000958A1Novel carriers and conjugation methodsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 1644US12036285B2Immunogenic conjugates and use thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jul 16, 2024·0 cites·21 claims
- 1744US2011159602A1Analysis of vi saccharidesBERTI FRANCESCO·Filed 2009·Application pending·0 cites
- 1840US2023137914A1nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOFGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →